Literature DB >> 31333048

Domain integration of ADAM family proteins: Emerging themes from structural studies.

Tom Cm Seegar1, Stephen C Blacklow1,2,3.   

Abstract

Keywords:  Metalloproteinase; biophysics; ectodomain shedding; notch signaling; signal transduction; structural biology

Year:  2019        PMID： 31333048      PMCID： PMC6920674          DOI： 10.1177/1535370219865901

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  64 in total

1.  MDC-L, a novel metalloprotease disintegrin cysteine-rich protein family member expressed by human lymphocytes.

Authors:  C M Roberts; P H Tani; L C Bridges; Z Laszik; R D Bowditch
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

2.  Functional analysis of secreted and transmembrane proteins critical to mouse development.

Authors:  K J Mitchell; K I Pinson; O G Kelly; J Brennan; J Zupicich; P Scherz; P A Leighton; L V Goodrich; X Lu; B J Avery; P Tate; K Dill; E Pangilinan; P Wakenight; M Tessier-Lavigne; W C Skarnes
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

Review 3.  Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF alpha and Notch.

Authors:  C P Blobel
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

4.  Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10.

Authors:  Tom C M Seegar; Lauren B Killingsworth; Nayanendu Saha; Peter A Meyer; Dhabaleswar Patra; Brandon Zimmerman; Peter W Janes; Eric Rubinstein; Dimitar B Nikolov; Georgios Skiniotis; Andrew C Kruse; Stephen C Blacklow
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

5.  Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.

Authors:  Hongwei Rao; Ganwei Lu; Hiroshi Kajiya; Veronica Garcia-Palacios; Noriyoshi Kurihara; Judy Anderson; Ken Patrene; Dean Sheppard; Harry C Blair; Jolene J Windle; Sun Jin Choi; G David Roodman
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

6.  ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site.

Authors:  Sylvain M Le Gall; Thorsten Maretzky; Priya D A Issuree; Xiao-Da Niu; Karina Reiss; Paul Saftig; Rama Khokha; Daniel Lundell; Carl P Blobel
Journal:  J Cell Sci       Date:  2010-10-27       Impact factor: 5.285

7.  Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.

Authors:  Dmitriy Minond; Mare Cudic; Nina Bionda; Marc Giulianotti; Laura Maida; Richard A Houghten; Gregg B Fields
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

8.  Phosphatidylserine exposure is required for ADAM17 sheddase function.

Authors:  Anselm Sommer; Felix Kordowski; Joscha Büch; Thorsten Maretzky; Astrid Evers; Jörg Andrä; Stefan Düsterhöft; Matthias Michalek; Inken Lorenzen; Prasath Somasundaram; Andreas Tholey; Frank D Sönnichsen; Karl Kunzelmann; Lena Heinbockel; Christian Nehls; Thomas Gutsmann; Joachim Grötzinger; Sucharit Bhakdi; Karina Reiss
Journal:  Nat Commun       Date:  2016-05-10       Impact factor: 14.919

9.  ADAM10 sheddase activation is controlled by cell membrane asymmetry.

Authors:  Florian Bleibaum; Anselm Sommer; Martin Veit; Björn Rabe; Jörg Andrä; Karl Kunzelmann; Christian Nehls; Wilmar Correa; Thomas Gutsmann; Joachim Grötzinger; Sucharit Bhakdi; Karina Reiss
Journal:  J Mol Cell Biol       Date:  2019-12-23       Impact factor: 6.216

Review 10.  The ADAM metalloproteinases.

Authors:  Dylan R Edwards; Madeleine M Handsley; Caroline J Pennington
Journal:  Mol Aspects Med       Date:  2008-08-15
View more
  6 in total

1.  Structural biology: Gaining atomic level insight into the biological function of macromolecules.

Authors:  Thomas B Thompson; Rhett A Kovall
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-13

2.  The ADAM9/UBN2/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer.

Authors:  Trang Thi-Huynh Le; Chia-Ling Hsieh; I-Hsuan Lin; Cheng-Ying Chu; Anh Duy Do; Seu-Hwa Chen; Katsumi Shigemura; Koichi Kitagawa; Masato Fujisawa; Ming-Che Liu; Kuan-Chou Chen; Shian-Ying Sung
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

3.  Crystal structure of the Tspan15 LEL domain reveals a conserved ADAM10 binding site.

Authors:  Colin H Lipper; Khal-Hentz Gabriel; Tom C M Seegar; Katharina L Dürr; Michael G Tomlinson; Stephen C Blacklow
Journal:  Structure       Date:  2021-11-04       Impact factor: 5.006

4.  Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours.

Authors:  Hengkang Yan; Mary E Vail; Linda Hii; Nancy Guo; Paul J McMurrick; Karen Oliva; Simon Wilkins; Nayanendu Saha; Dimitar B Nikolov; Fook-Thean Lee; Andrew M Scott; Peter W Janes
Journal:  Cancers (Basel)       Date:  2022-06-28       Impact factor: 6.575

5.  Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation.

Authors:  Qi Wang; Jia Wei; Xi Jia; Xiao Feng; Zhenghua Ji; Xueqiang Ji; Xuejun Shao
Journal:  BMC Pediatr       Date:  2022-03-30       Impact factor: 2.125

Review 6.  ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease.

Authors:  Francesca Tosetti; Massimo Alessio; Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.